Along with proteins, peptides have an increasingly important role in new drug development. Challenges in peptide formulation are, amongst others, short in-vivo half-life due to rapid enzymatic degradation. InnoCore’s sustained release technologies are capable of releasing peptides structurally intact over a period of time, ranging from days to several weeks. The top ten benefits of our sustained release technologies for peptides:


Read more about our polymer platform SynBiosys® and Ingell®